Meta-analysis of 13 RCTs (693 patients) with IBS: faecal microbiota transplantation versus placebo did not significantly reduce non-improvement of symptoms at 12 weeks by intention to treat (RR 0.72, 95% CI 0.50–1.03; very low certainty). Adverse events were similar.
Meta-analysisn = 693
Aumpan et al. Fecal Microbiota Transplantation for Symptom Improvement in Patients With Irritable Bowel Syndrome: Systematic Review and Meta-Analysis of Randomized Controlled Trials